Panacea Biotec Limited (PANACEABIO) Share Price
NSE · Healthcare · Biotechnology · ISIN INE922B01023
Key metrics
- Market Cap
- ₹2,394 Cr
- P/E Ratio
- —
- EPS
- -1.16
- Book Value
- 135.33
- P/B Ratio
- 2.86
- ROE
- -0.65%
- ROCE
- -4.42%
- Debt / Equity
- 0.03
- Net Margin
- -0.84%
- Revenue Growth
- 14.43%
- Profit Growth
- 35.84%
- Dividend Yield
- —
- 52W High
- ₹647.00
- 52W Low
- ₹292.40
- Market Cap Band
- small cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About Panacea Biotec Limited
Panacea Biotec Limited, a biotechnology company, engages in the research, development, manufacture, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products in India and internationally. It operates through Vaccines and Pharmaceutical formulations & Nutrition segments. The company's product portfolio includes prescription products in various therapeutic areas, such as oncology, diabetes, gastro-intestinal care, nephrology, orthopedics, pain management, and fever; cold and cough; and betacoronavirus, SARS-CoV-2, typhoid conjugate, pneumococcal conjugate, tetravalent dengue, Mpox, and hepatitis A vaccines, etc. It also offers health supplement products; and paediatric nutrition products under the ChilRunFull, ChilRun 7+, and ChillRun No Sucrose brands. In addition, the company engages in the real estate business. It exports its products to approximately 50 countries. The company has collaboration agreements with the Russian Direct Investment Fund for producing Covid-19 vaccine, and Sputnik-V; and the Indian Council of Medical Research for clinical trials of DengiAll vaccine. Panacea Biotec Limited was incorporated in 1984 and is based in New Delhi, India.
- Headquarters
- New Delhi, India
- Employees
- 2,149
- Promoter Holding
- 72.65%
The full Panacea Biotec Limited analysis
Create a free account to open the complete PANACEABIO deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.